Insider track record Other Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Emma Walmsley. Insider active across 1 company, notably GSK plc. Cumulatively, 84 reports have been recorded. Activity tracked since 9 August 2023. The latest transaction was disclosed on 9 December 2025 (Purchase). Regulator: RNS (LSE). All data is openly available.
Declarations 84 total
● Chief Executive Officer · Executives · 9 Dec 2025 · GSK plc 14 shares @ £18.0779 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:58b71e9c-e0b4-4fdd-8b21-5f1119d38ddd-0 Ideal exit: 5 Sept 2026 (T+270) ● Chief Executive Officer · Executives · 11 Nov 2025 · GSK plc 14 shares @ £18.1421 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:802a4789-60c0-4a7f-a34b-b750f1d9f048-0 Ideal exit: 8 Aug 2026 (T+270) ● Chief Executive Officer · Executives · 10 Oct 2025 · GSK plc 0
0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5862277-12 Ideal exit: 7 Jul 2026 (T+270) ● Chief Executive Officer · Executives · 10 Oct 2025 · GSK plc 3,924 shares @ £16.40 0.3% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5862277-0 ● Chief Executive Officer · Executives · 9 Oct 2025 · GSK plc 29 shares @ £16.3921 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5859068-0 Ideal exit: 6 Jul 2026 (T+270) ● Chief Executive Officer · Executives · 9 Oct 2025 · GSK plc 0
London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5859068-13 Ideal exit: 6 Jul 2026 (T+270) ● Chief Executive Officer · Executives · 9 Oct 2025 · GSK plc 14 shares @ £16.4086 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5857218-0 Ideal exit: 6 Jul 2026 (T+270) ● Chief Executive Officer · Executives · 9 Sept 2025 · GSK plc 18 shares @ £14.8572 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5815851-0 Ideal exit: 6 Jun 2026 (T+270) ● Chief Executive Officer · Executives · 11 Aug 2025 · GSK plc 18 shares @ £14.0844 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5777526-0 Ideal exit: 8 May 2026 (T+270) ● Chief Executive Officer · Executives · 11 Jul 2025 · GSK plc 0
London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5739159-4 Ideal exit: 7 Apr 2026 (T+270) ● Chief Executive Officer · Executives · 10 Jul 2025 · GSK plc 4,377 shares @ £14.545 0.3% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5737340-19 ● Chief Executive Officer · Executives · 9 Jul 2025 · GSK plc 16 shares @ £14.2075 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5737340-0 Ideal exit: 5 Apr 2026 (T+270) ● Chief Executive Officer · Executives · 10 Jul 2025 · GSK plc 0
0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5737340-31 Ideal exit: 6 Apr 2026 (T+270) ● Chief Executive Officer · Executives · 10 Jul 2025 · GSK plc 32 shares @ £14.4447 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5737340-9 Ideal exit: 6 Apr 2026 (T+270) ● Chief Executive Officer · Executives · 10 Jun 2025 · GSK plc 18 shares @ £14.9467 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:202506120600PR_NEWS_UKDISCLO_0053-0 Ideal exit: 7 Mar 2026 (T+270) ● Chief Executive Officer · Executives · 12 May 2025 · GSK plc 18 shares @ £13.5078 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5652536-0 Ideal exit: 6 Feb 2026 (T+270) ● Chief Executive Officer · Executives · 6 May 2025 · GSK plc 0
N/AGB00BN7SWP63⌘ RNS:5646935-0 ● Chief Executive Officer · Executives · 6 May 2025 · GSK plc 0
London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5646935-1 ● Chief Executive Officer · Executives · 16 Apr 2025 · GSK plc 0
London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5622701-12 Ideal exit: 11 Jan 2026 (T+270) ● Chief Executive Officer · Executives · 16 Apr 2025 · GSK plc 4,930 shares @ £12.75 0.3% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5622701-0 ● Chief Executive Officer · Executives · 10 Apr 2025 · GSK plc 0
London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5617047-8 Ideal exit: 5 Jan 2026 (T+270) ● Chief Executive Officer · Executives · 9 Apr 2025 · GSK plc 20 shares @ £12.6155 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5615070-0 Ideal exit: 4 Jan 2026 (T+270) ● Chief Executive Officer · Executives · 10 Apr 2025 · GSK plc 35 shares @ £13.1269 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5615070-9 Ideal exit: 5 Jan 2026 (T+270) ● Chief Executive Officer · Executives · 11 Mar 2025 · GSK plc 16 shares @ £15.4538 0.0% of flow London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5575192-0 Ideal exit: 6 Dec 2025 (T+270) ● Chief Executive Officer · Executives · 21 Feb 2025 · GSK plc 123,700 shares 0
London Stock Exchange (XLON)GB00BN7SWP63⌘ RNS:5553317-4 25 of 84 declarations
Load more (59 remaining) About Emma Walmsley Emma Walmsley is a declarant who has made 84 filings in total. In her most recent filings, she has executed a total purchase of 12825 EUR and a total sale of 3364176 EUR, with transactions ranging from August 10, 2023, to December 11, 2025. Her filings include significant amounts such as 9869570.80 EUR and 9180830.59 EUR, both published on February 21, 2025, and February 12, 2024, respectively.